Sign In
Buy NUVA
$39.75
+0 (+0%)
At Close: Nov 30, 2023
Bank of America, NuVasive fall; Tesla, Plantronics rise
08:32pm, Wednesday, 15'th Apr 2020
NEW YORK (AP) — Stocks that moved heavily or traded substantially on Wednesday:
Bank of America Corp., down $1.54 to $22.19.
The bank's first quarter profit fell by nearly half as it set aside money
Analysts Are Bullish on These Healthcare Stocks: Madrigal Pharmaceuticals (MDGL), NuVasive (NUVA)
10:03am, Wednesday, 15'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Madrigal Pharmaceuticals (MDGL) and NuVasive (NUVA) with
Analysts Are Bullish on These Healthcare Stocks: Madrigal Pharmaceuticals (MDGL), NuVasive (NUVA)
10:03am, Wednesday, 15'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Madrigal Pharmaceuticals
NuVasive (NASDAQ:NUVA) Receives "Buy" Rating from Piper Sandler
07:32am, Wednesday, 15'th Apr 2020
NuVasive (NASDAQ:NUVA)‘s stock had its “buy” rating reissued by research analysts at Piper Sandler in a research report issued to clients and investors on Tuesday, TipRanks reports. They current
Needham Reaffirms Their Hold Rating on NuVasive (NUVA)
01:13am, Wednesday, 15'th Apr 2020
Needham analyst Michael Matson maintained a Hold rating on NuVasive (NUVA) yesterday. The company's shares closed last Tuesday at $56.46. According to
Needham Reaffirms Their Hold Rating on NuVasive (NUVA)
01:13am, Wednesday, 15'th Apr 2020
Needham analyst
Michael Matson
maintained a
Hold
rating on NuVasive (
NUVA
–
Research Report
) yesterday. The company’s shares closed last Tuesday at $56.46.
According to
TipRanks.com
, Matson is
BTIG Maintains Their Buy Rating on NuVasive (NUVA)
10:13pm, Tuesday, 14'th Apr 2020
BTIG analyst Ryan Zimmerman maintained a Buy rating on NuVasive (NUVA) today and set a price target of $67.00. The company's shares closed last Tuesday at
BTIG Maintains Their Buy Rating on NuVasive (NUVA)
10:13pm, Tuesday, 14'th Apr 2020
BTIG analyst Ryan Zimmerman maintained a Buy rating on NuVasive (NUVA – Research Report) today and set a price target
BRIEF-Nuvasive Implements Compensation Reductions For Board Of Directors
08:05pm, Tuesday, 14'th Apr 2020
NuVasive Inc:
NuVasive Provides Business Update Related to COVID-19
08:02pm, Tuesday, 14'th Apr 2020
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today provided an update o
NuVasive sees Q2 impacted by Q1 decline in elective procedure volumes NUVA
09:09am, Tuesday, 14'th Apr 2020
NuVasive sees Q2 impacted by Q1 decline in elective procedure volumes NUVA
NuVasive sees Q1 revenue $259M-$-261M, consensus $282M NUVA
09:06am, Tuesday, 14'th Apr 2020
NuVasive sees Q1 revenue $259M-$-261M, consensus $282M NUVA
How Does NuVasive’s (NASDAQ:NUVA) P/E Compare To Its Industry, After Its Big Share Price Gain?
11:30am, Monday, 13'th Apr 2020
NuVasive (NASDAQ:NUVA) shareholders are no doubt pleased to see that the share price has bounced 35% in the last month...
A Rising Share Price Has Us Looking Closely At NuVasive, Inc.'s (NASDAQ:NUVA) P/E Ratio
11:24am, Monday, 13'th Apr 2020
Those holding NuVasive (NASDAQ:NUVA) shares must be pleased that the share price has rebounded 35% in the last thirty...
